![Ian MacLachlan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ian MacLachlan
Corporate Officer/Principal chez New York Academy of Sciences
Postes actifs de Ian MacLachlan
Sociétés | Poste | Début | Fin |
---|---|---|---|
New York Academy of Sciences
![]() New York Academy of Sciences Miscellaneous Commercial ServicesCommercial Services New York Academy of Sciences is an independent, not-for-profit organization, which engages in the advancement of scientific research, education, and policy. The company was founded in 1817 and is headquartered in New York, NY. | Corporate Officer/Principal | - | - |
Oligonucleotide Therapeutics Society, Inc.
![]() Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators. | Corporate Officer/Principal | - | - |
American Society of Gene Therapy | Corporate Officer/Principal | - | - |
Historique de carrière de Ian MacLachlan
Anciens postes connus de Ian MacLachlan
Sociétés | Poste | Début | Fin |
---|---|---|---|
ARBUTUS BIOPHARMA CORPORATION | Directeur Technique/Scientifique/R&D | 30/05/2008 | 31/12/2014 |
Protiva Biotherapeutics, Inc.
![]() Protiva Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Protiva Biotherapeutics, Inc. develops pharmaceutical products for human diseases. The firm offers drugs for cancer, influenza (including H5N1), Ebola, inflammatory diseases and other chronic viral infections. The company was founded in September, 2000 and is headquartered in Seattle, WA. | Directeur Technique/Scientifique/R&D | 01/01/2000 | 02/12/2008 |
Fondateur | 01/01/2000 | 02/12/2008 |
Formation de Ian MacLachlan
University of Alberta | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 5 |
Canada | 3 |
Opérationnelle
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Founder | 1 |
Sectorielle
Health Technology | 3 |
Commercial Services | 3 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
ARBUTUS BIOPHARMA CORPORATION | Health Technology |
Entreprise privées | 4 |
---|---|
Protiva Biotherapeutics, Inc.
![]() Protiva Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Protiva Biotherapeutics, Inc. develops pharmaceutical products for human diseases. The firm offers drugs for cancer, influenza (including H5N1), Ebola, inflammatory diseases and other chronic viral infections. The company was founded in September, 2000 and is headquartered in Seattle, WA. | Health Technology |
New York Academy of Sciences
![]() New York Academy of Sciences Miscellaneous Commercial ServicesCommercial Services New York Academy of Sciences is an independent, not-for-profit organization, which engages in the advancement of scientific research, education, and policy. The company was founded in 1817 and is headquartered in New York, NY. | Commercial Services |
Oligonucleotide Therapeutics Society, Inc.
![]() Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators. | Commercial Services |
American Society of Gene Therapy |
- Bourse
- Insiders
- Ian MacLachlan
- Expérience